SANA · Sana Biotechnology Inc. Common Stock
View on chartInsiders & Stakes
| Keith Crandell Director | ▲ Buy | Open Market | 12,446,022 Shares held | 2/8/2024 | View profile |
| Robert Nelsen Director | ▲ Buy | Open Market | 12,446,022 Shares held | 2/8/2024 | View profile |
| ARCH Venture Fund X, L.P. 10% Owner | ▲ Buy | Open Market | 12,446,022 Shares held | 2/8/2024 | View profile |
| Steve Harr President & CEO | ▼ Sell | Tax Withholding | 7,944,251 Shares held | 3/9/2026 | View profile |
| Hans Edgar Bishop Director | ▲ Buy | Grant | 5,863,480 Shares held | 10/5/2026 | View profile |
| FMR LLC | ▼ Sell | Open Market | 4,541,511 Shares held | 1/8/2025 | View profile |
| Richard Mulligan Director | ▼ Sell | Open Market | 2,698,121 Shares held | 9/25/2024 | View profile |
| AGARWAL SUNIL Director | ▼ Sell | Open Market | 1,550,000 Shares held | 9/16/2021 | View profile |
| Flagship Ventures Fund V General Partner LLC 10% Owner | ▼ Sell | Open Market | 1,380,277 Shares held | 6/7/2023 | View profile |
| Hordo Christian EVP, Chief Business Officer | ▼ Sell | Open Market | 867,455 Shares held | 12/15/2023 | View profile |
| MacDonald James J. EVP & General Counsel | ▲ Buy | Option Exercise | 497,396 Shares held | 6/13/2022 | View profile |
| Susan D. Wyrick See Remarks | ▼ Sell | Tax Withholding | 196,196 Shares held | 3/9/2026 | View profile |
| PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer | ▼ Sell | Tax Withholding | 183,352 Shares held | 8/27/2026 | View profile |
| Yang Patrick Y Director | ▼ Sell | Open Market | 149,250 Shares held | 3/8/2024 | View profile |
| Bernard J. Cassidy EVP & General Counsel | ▼ Sell | Tax Withholding | 112,990 Shares held | 3/10/2025 | View profile |
| Bilenker Joshua H. | ▲ Buy | Open Market | 20,000 Shares held | 2/3/2021 | View profile |
| Mary Agnes Wilderotter Director | ▲ Buy | Grant | 7,106 Shares held | 1/5/2024 | View profile |
| Flagship Pioneering Inc. 10% Owner | ▼ Sell | Other | 0 Shares held | 9/13/2023 | View profile |
Transaction History
| Hans Edgar Bishop | ▲ Buy | Grant | 8,680 | $0 | 10/5/2026 |
| PATEL DHAVALKUMAR DHIRAJLAL | ▼ Sell | Tax Withholding | 41,158 | $169K | 8/27/2026 |
| PATEL DHAVALKUMAR DHIRAJLAL | ▲ Buy | Option Exercise | 125,000 | $0 | 8/26/2026 |
| Hans Edgar Bishop | ▲ Buy | Grant | 6,297 | $0 | 7/6/2026 |
| Hans Edgar Bishop | ▲ Buy | Grant | 7,763 | $0 | 4/6/2026 |
| Steve Harr | ▼ Sell | Tax Withholding | 11,526 | $36K | 3/9/2026 |
| Steve Harr | ▼ Sell | Tax Withholding | 12,819 | $40K | 3/9/2026 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 3,342 | $10K | 3/9/2026 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 1,045 | $3K | 3/9/2026 |
| Steve Harr | ▲ Buy | Option Exercise | 50,000 | $0 | 3/7/2026 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 3,250 | $0 | 3/7/2026 |
| Steve Harr | ▲ Buy | Option Exercise | 41,666 | $0 | 3/6/2026 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 10,416 | $0 | 3/6/2026 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 491 | $2K | 3/3/2026 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 1,525 | $0 | 3/2/2026 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 2,407 | $10K | 1/5/2026 |
| Hans Edgar Bishop | ▲ Buy | Grant | 6,157 | $0 | 1/5/2026 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 7,500 | $0 | 1/2/2026 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 873 | $5K | 12/15/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 3,400 | $0 | 12/13/2025 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 2,565 | $11K | 12/4/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 10,000 | $0 | 12/3/2025 |
| Hans Edgar Bishop | ▲ Buy | Grant | 5,628 | $0 | 10/6/2025 |
| Hans Edgar Bishop | ▲ Buy | Grant | 7,842 | $0 | 7/7/2025 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 2,567 | $6K | 6/4/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 10,000 | $0 | 6/3/2025 |
| Hans Edgar Bishop | ▲ Buy | Grant | 16,339 | $0 | 4/7/2025 |
| Bernard J. Cassidy | ▼ Sell | Tax Withholding | 2,833 | $7K | 3/10/2025 |
| Steve Harr | ▼ Sell | Tax Withholding | 12,820 | $33K | 3/10/2025 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 836 | $2K | 3/10/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 3,250 | $0 | 3/7/2025 |
| Bernard J. Cassidy | ▲ Buy | Option Exercise | 11,041 | $0 | 3/7/2025 |
| Steve Harr | ▲ Buy | Option Exercise | 50,000 | $0 | 3/7/2025 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 490 | $1K | 3/3/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 1,525 | $0 | 3/2/2025 |
| FMR LLC | ▼ Sell | Open Market | 100,000 | $611K | 1/8/2025 |
| FMR LLC | ▼ Sell | Open Market | 25,000 | $163K | 1/8/2025 |
| FMR LLC | ▼ Sell | Open Market | 164,912 | $1.1M | 1/8/2025 |
| FMR LLC | ▼ Sell | Open Market | 1,000 | $7K | 1/8/2025 |
| Hans Edgar Bishop | ▲ Buy | Grant | 14,285 | $0 | 1/6/2025 |
| Susan D. Wyrick | ▲ Buy | Option Exercise | 5,000 | $0 | 1/2/2025 |
| Susan D. Wyrick | ▼ Sell | Tax Withholding | 1,566 | $3K | 1/2/2025 |
| Hans Edgar Bishop | ▲ Buy | Grant | 5,938 | $0 | 10/7/2024 |
| Richard Mulligan | ▼ Sell | Open Market | 150,000 | $583K | 9/25/2024 |
| Richard Mulligan | ▼ Sell | Open Market | 150,000 | $613K | 9/24/2024 |
| Hans Edgar Bishop | ▲ Buy | Grant | 4,911 | $0 | 7/5/2024 |
| Hans Edgar Bishop | ▲ Buy | Grant | 2,774 | $0 | 4/5/2024 |
| Yang Patrick Y | ▼ Sell | Open Market | 25,000 | $236K | 3/8/2024 |
| Robert Nelsen | ▲ Buy | Open Market | 363,637 | $2.0M | 2/8/2024 |
| Robert Nelsen | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| Keith Crandell | ▲ Buy | Open Market | 363,637 | $2.0M | 2/8/2024 |
| Keith Crandell | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| ARCH Venture Fund X, L.P. | ▲ Buy | Open Market | 363,637 | $2.0M | 2/8/2024 |
| ARCH Venture Fund X, L.P. | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| ARCH Venture Fund X, L.P. | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| Keith Crandell | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| Robert Nelsen | ▲ Buy | Open Market | 727,272 | $4.0M | 2/8/2024 |
| Hans Edgar Bishop | ▲ Buy | Grant | 4,901 | $0 | 1/5/2024 |
| Mary Agnes Wilderotter | ▲ Buy | Grant | 1,470 | $0 | 1/5/2024 |
| Hordo Christian | ▼ Sell | Open Market | 75,000 | $300K | 12/15/2023 |
| Hans Edgar Bishop | ▲ Buy | Grant | 6,925 | $0 | 10/5/2023 |
| Mary Agnes Wilderotter | ▲ Buy | Grant | 2,077 | $0 | 10/5/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 70,813 | — | 9/13/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 2,431,281 | — | 9/13/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 1,181,745 | — | 9/13/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 345,069 | — | 9/13/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 4,926,378 | — | 9/13/2023 |
| Flagship Pioneering Inc. | ▼ Sell | Other | 2,825,989 | — | 9/13/2023 |
| Mary Agnes Wilderotter | ▲ Buy | Grant | 1,245 | $0 | 7/5/2023 |
| Hans Edgar Bishop | ▲ Buy | Grant | 4,152 | $0 | 7/5/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 22,760 | $142K | 6/7/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 177,240 | $1.1M | 6/7/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 181,461 | $1.1M | 6/6/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 22,297 | $141K | 6/6/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 9,330 | $58K | 5/26/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 72,670 | $452K | 5/26/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 102,245 | $649K | 5/25/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 13,127 | $83K | 5/25/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 308,290 | $2.0M | 5/24/2023 |
| Flagship Ventures Fund V General Partner LLC | ▼ Sell | Open Market | 39,580 | $260K | 5/24/2023 |
| Hans Edgar Bishop | ▲ Buy | Grant | 7,716 | $0 | 4/5/2023 |
| Mary Agnes Wilderotter | ▲ Buy | Grant | 2,314 | $0 | 4/5/2023 |
| Hans Edgar Bishop | ▲ Buy | Grant | 6,702 | $0 | 1/5/2023 |
| Robert Nelsen | ▲ Buy | Grant | 536 | $0 | 1/5/2023 |
| Robert Nelsen | ▲ Buy | Grant | 321 | $0 | 10/5/2022 |
| Hans Edgar Bishop | ▲ Buy | Grant | 4,012 | $0 | 10/5/2022 |
| Robert Nelsen | ▲ Buy | Grant | 266 | $0 | 7/5/2022 |
| Hans Edgar Bishop | ▲ Buy | Grant | 3,328 | $0 | 7/5/2022 |
| MacDonald James J. | ▲ Buy | Option Exercise | 66,796 | $99K | 6/13/2022 |
| MacDonald James J. | ▲ Buy | Grant | 1,183 | $5K | 5/13/2022 |
| Hans Edgar Bishop | ▲ Buy | Grant | 2,880 | $0 | 4/5/2022 |
| Robert Nelsen | ▲ Buy | Grant | 230 | $0 | 4/5/2022 |
| Yang Patrick Y | ▲ Buy | Open Market | 28,000 | $204K | 3/21/2022 |
| MacDonald James J. | ▼ Sell | Open Market | 333 | $2K | 2/18/2022 |
| MacDonald James J. | ▲ Buy | Grant | 1,000 | $18K | 11/15/2021 |
| AGARWAL SUNIL | ▼ Sell | Open Market | 1,627 | $42K | 9/16/2021 |
| AGARWAL SUNIL | ▼ Sell | Open Market | 58,373 | $1.5M | 9/15/2021 |
| Hordo Christian | ▼ Sell | Open Market | 1,477 | $37K | 9/10/2021 |
| Hordo Christian | ▲ Buy | Option Exercise | 39,205 | $58K | 9/9/2021 |
| Hordo Christian | ▼ Sell | Open Market | 39,205 | $981K | 9/9/2021 |
| Hordo Christian | ▼ Sell | Open Market | 25,466 | $637K | 9/9/2021 |
| Hordo Christian | ▲ Buy | Option Exercise | 700 | $1K | 9/3/2021 |
| Hordo Christian | ▼ Sell | Open Market | 700 | $18K | 9/3/2021 |
| Hordo Christian | ▲ Buy | Option Exercise | 6,558 | $10K | 9/2/2021 |
| Hordo Christian | ▼ Sell | Open Market | 6,558 | $164K | 9/2/2021 |
| Hordo Christian | ▼ Sell | Open Market | 1,400 | $35K | 9/2/2021 |
| Hordo Christian | ▲ Buy | Option Exercise | 1,134 | $2K | 9/1/2021 |
| Hordo Christian | ▼ Sell | Open Market | 1,134 | $28K | 9/1/2021 |
| Hordo Christian | ▼ Sell | Open Market | 3,002 | $75K | 9/1/2021 |
| Hordo Christian | ▲ Buy | Option Exercise | 1,100 | $2K | 8/30/2021 |
| Hordo Christian | ▼ Sell | Open Market | 1,100 | $28K | 8/30/2021 |
| Hordo Christian | ▼ Sell | Open Market | 1,200 | $30K | 8/30/2021 |
| Steve Harr | ▼ Sell | Gift | 167,000 | $0 | 4/14/2021 |
| Steve Harr | ▼ Sell | Gift | 167,000 | $0 | 4/14/2021 |
| Bilenker Joshua H. | ▲ Buy | Open Market | 20,000 | $500K | 2/3/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Sana Biotechnology Featured in Diabetes Treatment Analysis
Sana Biotechnology was the subject of a recent analysis titled 'A Shot At Diabetes,' which likely examines the company's potential in treating the condition. This coverage places the stock in the spotlight for investors watching biotech developments. The stock is currently trading near its support level, with an RSI indicating it may be oversold.
Sana Biotechnology Featured in Diabetes Treatment Analysis. Sana Biotechnology was the subject of a recent analysis titled 'A Shot At Diabetes,' which likely examines the company's potential in treating the condition. This coverage places the stock in the spotlight for investors watching biotech developments. The stock is currently trading near its support level, with an RSI indicating it may be oversold.